Age: 16.0
Sex: M
Vaccine: HPV4
Symptoms: Hypermobility syndrome, Hypotension, Inappropriate schedule of product administration, Musculoskeletal pain, Nervousness
Clinical narrative: postural orthostatic tachycardia (POTS); antalgic gait; facet syndrome; joint hypermobility; musculoskeletal pain; small fiber neuropathy; low back pain; Raynaud's phenomena; sacroiliac pain; synovitis; hypotension; autoimmune and neurological injuries; constellation of adverse symptoms, complications, injuries, and other adverse events; constellation of adverse symptoms, complications, injuries, and other adverse events; received his second and third dosages of Gardasil when he was 21.; Information has been received from a lawyer regarding a case in litigation and referred to a currently adult male patient (pt) (exact age not provided). Prior to receiving quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL), the pt was healthy. His other medical history, concurrent conditions and concomitant therapies were not provided. On an unknown date (at the age of 16 years old), the pt was vaccinated with the first dose of quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) intramuscular injection (exact dose, route of administration, anatomical location, lot # and expiration date were not provided), as recommended by his health care providers, with his and his mother's consent, for prophylaxis (reported as for preventing cancer). On unknown date (at the age of 21 years old), the pt was vaccinated with the second and third doses of quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) intramuscular injection (exact doses, route of administration, anatomical locations, lots # and expiration dates were not provided) (Inappropriate schedule of product administration). On unknown date following his quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) vaccinations, pt developed tachycardia, fatigue, joint pain, dizziness, weakness upon standing, chest pains, blurred vision, disequilibrium, feeling shaky and unsteady, lightheadedness, and brain fog. As the months progressed, so did pt's symptoms. He was seen by multiple physicians and specialists for his complaints. As a result of his post- quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) symptoms, pt had been unable to engage in activities that a young person his age would normally enjoy, and his symptoms had made it difficult for him to function. His high school and college performance suffered because of his symptoms. Based upon his chronic and severe post- quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) symptoms, pt has been diagnosed with postural orthostatic tachycardia (POTS) with hypotension, antalgic gait (Gait disturbance), facet syndrome (Facet joint syndrome), joint hypermobility (Hypermobility syndrome), musculoskeletal pain, small fiber neuropathy, low back pain, sacroiliac pain (Sacral pain), Raynaud's phenomena without gangrene, and synovitis. Pt contended that his quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) injections caused him to develop serious and debilitating autoimmune and neurological injuries (Autoimmune disorder), including but not limited to POTS, as well as a constellation of adverse symptoms, complications, injuries, and other adverse events, many of which are alleged herein and all of which were caused by quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) or otherwise linked to his quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL)-induced autoimmune disorder (Ill-defined disorder; Adverse event). As a proximate result of quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL), the pt had suffered and continued to suffer severe and permanent physical injuries and associated symptomatology and had suffered severe and permanent emotional injuries, including pain and suffering. He also had a substantial fear of suffering additional and ongoing harms, including but not limited to now being at an increased risk of cancer, and future symptoms and harms associated with his autoimmune disease and other injuries caused by quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL). As a direct and proximate result of his quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL)-induced injuries, the pt suffered and continued to suffer economic losses, including considerable financial expenses for medical care and treatment, and diminished income capacity, and he would continue to incur these losses and expenses in the future. The outcome of all events was considered to be not recovered. The lawyer considered all events to be related to quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL).  The lawyer considered all events to be disabling.  Upon internal review, the event autoimmune disorder was determined as medically significant.